메뉴 건너뛰기




Volumn 73, Issue 12, 2010, Pages 615-616

Old Age May Not Be a Contraindication to the Use of Metformin

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BUFORMIN; CREATININE; LACTIC ACID; METFORMIN; PHENFORMIN;

EID: 78649953218     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(10)70134-9     Document Type: Editorial
Times cited : (1)

References (8)
  • 2
    • 0032511566 scopus 로고    scopus 로고
    • UKPDS Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. United Kingdom Prospective Diabetes Study
    • UKPDS Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. United Kingdom Prospective Diabetes Study. Lancet 1998, 352:854-865.
    • (1998) Lancet , vol.352 , pp. 854-865
  • 3
    • 60449089649 scopus 로고    scopus 로고
    • American Diabetes Association, European Association for Study of Diabetes Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, European Association for Study of Diabetes Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32:193-203.
    • (2009) Diabetes Care , vol.32 , pp. 193-203
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3    Ferrannini, E.4    Holman, R.R.5    Sherwin, R.6    Zinman, B.7
  • 5
    • 33645516747 scopus 로고    scopus 로고
    • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
    • CD002967.
    • Salpeter SR, Greyber E, Pasternak GA, Salpeter EE Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2006, CD002967. 10.1002/14651858.CD002967.pub2.
    • (2006) Cochrane Database Syst Rev
    • Salpeter, S.R.1    Greyber, E.2    Pasternak, G.A.3    Salpeter, E.E.4
  • 6
    • 78649956458 scopus 로고    scopus 로고
    • Fasting plasma lactate concentrations in ambulatory elderly patients with type 2 diabetes receiving metformin therapy: a retrospective cross-sectional study
    • Lin YC, Lin LY, Wang HF, Lin HD Fasting plasma lactate concentrations in ambulatory elderly patients with type 2 diabetes receiving metformin therapy: a retrospective cross-sectional study. J Chin Med Assoc 2010, 73:617-622.
    • (2010) J Chin Med Assoc , vol.73 , pp. 617-622
    • Lin, Y.C.1    Lin, L.Y.2    Wang, H.F.3    Lin, H.D.4
  • 7
    • 28444452977 scopus 로고    scopus 로고
    • Contraindications can damage your health-is metformin a case in point?
    • Holstein A, Stumvoll M Contraindications can damage your health-is metformin a case in point?. Diabetologia 2005, 48:2454-2459.
    • (2005) Diabetologia , vol.48 , pp. 2454-2459
    • Holstein, A.1    Stumvoll, M.2
  • 8
    • 0029946976 scopus 로고    scopus 로고
    • Metformin treatment in NIDDM patients with mild renal impairment
    • Conolly V, Kesson CM Metformin treatment in NIDDM patients with mild renal impairment. Postgrad Med J 1996, 72:352-354.
    • (1996) Postgrad Med J , vol.72 , pp. 352-354
    • Conolly, V.1    Kesson, C.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.